Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
2.990
-0.070 (-2.29%)
Apr 23, 2026, 11:12 AM EDT - Market open
Cyclerion Therapeutics Market Cap
Cyclerion Therapeutics has a market cap or net worth of $12.64 million as of April 23, 2026. Its market cap has increased by 100.95% in one year.
Market Cap
12.64M
Enterprise Value
9.69M
1-Year Change
100.95%
Ranking
Category
Stock Price
$2.99
Market Cap Chart
Since March 18, 2019, Cyclerion Therapeutics's market cap has decreased from $193.31M to $12.64M, a decrease of -93.46%. That is a compound annual growth rate of -31.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 12.93M | 167.53% |
| Dec 31, 2025 | 4.83M | -40.68% |
| Dec 31, 2024 | 8.15M | -0.51% |
| Dec 29, 2023 | 8.19M | -71.30% |
| Dec 30, 2022 | 28.54M | -61.69% |
| Dec 31, 2021 | 74.50M | -28.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Soligenix | 13.66M |
| BioCardia | 13.44M |
| Intensity Therapeutics | 13.34M |
| Moleculin Biotech | 13.23M |
| Traws Pharma | 13.10M |
| BioVie | 12.59M |
| Chemomab Therapeutics | 12.38M |
| CytoMed Therapeutics | 12.07M |